BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ultragenyx Pharmaceuticals 

77 Digital Drive
Suite 210
Novato  California  94949  U.S.A.
Phone: 415-884-0223 Fax: 415-884-0562


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Ultragenyx Pharmaceuticals (RARE) To Present At The Cowen and Company 35th Annual Health Care Conference In Boston 2/25/2015 8:00:48 AM
Ultragenyx Pharmaceuticals (RARE) Appoints Michael Narachi To Board Of Directors 2/24/2015 7:41:21 AM
Ultragenyx Pharmaceuticals (RARE) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/17/2015 8:09:06 AM
Ultragenyx Pharmaceuticals (RARE) Announces Positive 36-Week Data From Phase 1/2 Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis 7 2/11/2015 7:34:24 AM
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 2/5/2015 11:12:27 AM
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 2/4/2015 7:40:34 AM
Ultragenyx Pharmaceuticals (RARE) Announces Intent To File For Conditional Approval In Europe For Sialic Acid Extended-Release Tablets In Hereditary Inclusion Body Myopathy 1/12/2015 7:22:23 AM
Ultragenyx Pharmaceuticals (RARE) Announces License Of Intellectual Property Related To The Treatment Of Huntington's Disease With Triheptanoin 1/8/2015 7:55:26 AM
Ultragenyx Pharmaceuticals (RARE) Initiates New Development Program Studying KRN23 For The Treatment Of Tumor-Induced Osteomalacia 1/6/2015 7:42:09 AM
Ultragenyx Pharmaceuticals (RARE) To Present At The J.P. Morgan Healthcare Conference 1/5/2015 7:26:43 AM
123456789